The Liver Week 2026

The Liver Week 2026

ABSTRACT

Turning Evidence into New Standards inLiver Disease Care

June 11-13, 2026ICONRAD, Seoul, Korea

SUBMISSION GUIDELINES PRESENTATION GUIDELINES AWARD PROGRAM

Submission Guidelines

AbstractSubmission Deadline

Wednesday, March 4, 2026

ABSTRACT SUBMISSION PROCESS

  •  Sign Up

    If you are already signed-up on this website, you can use the account for your abstract submission.

  • Submission and Confirmation

    After your abstract submission, a confirmation letter will be sent to you via e-mail.

  •  My Page

    To review or modify your submitted abstracts, visit 'My Page'.

  • Acceptance
    Notification

    An acceptance notification will be sent to you via e-mail.

IMPORTANT NOTES:

  • Presenting Author: The presenting author must be one of the authors listed in the abstract.
  • Submission by First Author: The abstract submission should be done by the first author.
  • Conference Registration: All presenting authors must register and pay for the conference by Monday, April 27, 2026.
  • Language: Abstracts must be submitted in English.
  • No Withdrawals or Updates: After acceptance notification, abstracts cannot be withdrawn or updated.

ABSTRACT CATEGORY

An abstract can be submitted for presentation at the conference in one of the following categories:
ORAL PRESENTATION
OR
POSTER EXHIBITION

GUIDELINES FOR ABSTRACT SUBMISSION

Please adhere to the following formatting guidelines when submitting abstracts for the conference. 

  • Abstract Title: must not exceed 20 words (First letter of each word in uppercase, except for articles, prepositions, and conjunctions).
  • Abstract Text: must not exceed 300 words (excluding the Title, Authors, and Affiliations).
  • An Acceptable Structure of an abstract must consist of the following components:
  • Background/Aim: A statement of the hypothesis or research question.
  • Methods: An explanation of the study design and experimental methods used.
  • Results:
    • A concise summary of the major findings of the experiment or study.
    • Sufficient data must be provided to permit evaluation by the reviewers and public reading the abstract.
    • Statements such as "The data will be discussed" are not acceptable.
  • Conclusion(s): Summary of the overall findings and the importance of the study.
  • Graphics and Tables can be submitted as part of an abstract. The maximum file size of each graphic/tables is 500 KB.
  • Author Names and Affiliations:
    Up to 15 authors and affiliations may be included on each abstract. All authors must have consented to the abstract submission.
    Do not reference institution names, locations, or funding sources in the abstract.
  • Presenting authors are responsible for proofreading before submission. No edits will be allowed in submitted abstracts for typing, spelling, or grammatical errors.

SUGGESTED TOPICS

  • HBV, Basic / HBV, Clinical
  • HCV, Basic / HCV, Clinical
  • Liver Cirrhosis, Portal Hypertension with Cx. Basic / Liver Cirrhosis, Portal Hypertension with Cx. Clinical
  • MASLD, Basic / MASLD, Clinical
  • Alcohol-Related Liver Disease, Basic / Alcohol-Related Liver Disease, Clinical
  • Autoimmune Liver Disease
  • Acute Liver Failure and Drug-Induced Liver Injury
  • Liver Cancer, Basic / Liver Cancer, Clinical
  • Liver Surgery
  • Biliary and Pancreatic Surgery
  • Liver Transplantation
  • Others, Medical / Others, Surgical

NOTIFICATION OF ACCEPTANCE

  • Notification of Acceptance: Presenting authors and corresponding authors will be notified of their acceptance status by April 6th, 2026.
  • Inform Co-Authors: Presenting authors are responsible for informing co-authors of the acceptance.
  • Organizing Committee Rights: The Organizing Committee reserves the right to accept or decline submissions and to select the format of the presentation.

ABSTRACT MODIFICATION OR WITHDRAWAL

  • Presenting Authors may modify or withdraw the submitted abstract at My Page prior to the submission deadline.
  • Following receiving a notification of acceptance via email, any abstracts cannot be modified or withdrawn.

QUESTIONS

  • For questions regarding Abstract Submission, please contact:  Conference Secretariat at abstract@hbni.co.kr.

📢 Late-Breaking Abstract Submission

We are pleased to announce a new and exclusive opportunity at The Liver Week 2026 — the Late-Breaking Abstract Plenary Session.

This special session is designed to showcase outstanding scientific research that could not be presented at EASL 2026 or missed the original abstract submission deadline for The Liver Week 2026. The Scientific Committee will carefully select high-impact studies that provide significant and novel contributions to the field of hepatology.

This is the first time such a program is being introduced, aiming to spotlight cutting-edge findings that emerged after the standard submission period or were not previously presented on the international stage.

We invite researchers with innovative, high-quality, and time-sensitive studies to seize this rare opportunity to present their work to a global audience.